It is projected that the global lipid nanoparticles industry size will be valued at US$ 877.8 million in 2023. The market is expected to expand at a CAGR of 14.2% between 2023 and 2033, reaching approximately US$ 3.3 billion by 2033, due to rising health concerns about dietary supplements as a result of Covid-19 and increasing dietary supplement use.
The rapid increase in population in regions such as Asia Pacific, Europe, and North America is one of the major factors that is expected to contribute to the demand for products such as pharmaceutical & healthcare, dietary supplements, functional food, functional beverages, cosmetic & personal care, and more. The high content of omega 3 and omega 6 in lipids is the primary factor driving their significant use in food & beverage products.
To Remain Ahead of Your Competitors, Request For A Sample! https://www.futuremarketinsights.com/reports/sample/rep-gb-15992
However, the market growth globally is hindered by rising global prices of fatty acids and other raw materials, which fluctuate due to the impact of the COVID-19 and the ongoing European geopolitical conflict. In addition, market players are focusing on R&D and coming up with new advancements in Lipid Nanoparticles technology, which is projected to create lucrative opportunities for the market in the near future.
Factors such as the increasing demand for medicines due to high incidence of cancer, chronic diseases, as well as growing focus on physical well-being are expected to propel the sales of pharmaceutical lipids over the analysis period. Pharmaceutical excipients aid lipids to achieve better functionalities, such as longer shelf-life, and boosts the efficacy in formulations. In addition, rising demand in emerging economies is pushing local drug production, which is augmenting the sales in the market.
Advancements in the compositions of lipid nanoparticles for in-vivo systemic delivery of mRNA are also creating lucrative avenues for market expansion. The key manufacturing companies in the Lipid Nanoparticles Industry are focusing on developing lipid nanoparticle (LNP) based drugs, in order to address certain medical challenges. In addition, they are focusing on collaborations with government organizations to establish new lipid production facilities.
The major players are investing heavily in product development activities, and their approach towards enhancing the business through product launch and acquisition is projected to fuel the growth of the global pharmaceutical lipids market in the forthcoming years.
Key Takeaways from the Market Study:
- Global Lipid Nanoparticles Industry was valued at US$ 781.0 Million by 2022-end
- From 2018 to 2022, the market demand expanded at a CAGR of 6.2%
- By Type, the Solid Lipid Nanoparticles segment of the market constitutes the bulk of the market with a market share of 45%
- By End-User, the Pharmaceutical & Biotechnology segment dominates the market with a share of 43%
- From 2023 to 2033, Lipid Nanoparticles sales are expected to flourish at a CAGR of 13.6%.
- By 2033, the market value of Lipid Nanoparticles is expected to reach US$ 3,175.5 Million.
Leading manufacturers are focused on implementing technological advancements to reduce their drug development and manufacturing costs. This, in turn is expected to boost the growth of the Lipid Nanoparticles Industry during the forecast period, remarks an FMI analyst.
Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-15992
Competitive Landscape:
Prominent players in the Lipid Nanoparticles Industry:
- Merck KGaA
- Evonik Industries AG
- Gattefosse
- Precision NanoSystems
- IOI Oleo GmbH
- Genevant Sciences
- Exelead
- Avanti Polar Lipids
- Nippon Fine Chemicals Co. Ltd.
- Lipoid GmbH
- Cargill, Incorporated
- BASF SE
- Archer Daniels Midland Company
- Koninklijke DSM N.V.
Recent Developments:
- In October 2022, Polypeptide Therapeutic Solutions (PTS), key player in the manufacturing and development of polyamino-acid based delivery systems expanded its drug delivery capabilities including novel nanoparticle formulation and functional lipid excipients.
- In September 2022, National Institute of Allergy and Infectious Diseases awarded USD 13.8 million contract to the University of California for conducting immune profiling of lipid nanoparticles to study their role in increasing vaccine protective responses.
Key Segments Covered in the Lipid Nanoparticles Industry Analysis:
Lipid Nanoparticles Industry by Type:
- Solid Lipid Nanoparticles (SLNs)
- Nanostructured Lipid Carriers (NLCs)
- Others
Lipid Nanoparticles Industry by Application:
- Therapeutics
- Research
Lipid Nanoparticles Industry by End-User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
Lipid Nanoparticles Industry by Region:
- North America
- Europe
- Asia Pacific
- Rest of the World
Ignite Innovation with Customization: Uncover the Possibilities in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-15992
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
